Aster DM Healthcare Limited has announced that its subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, has allotted compulsory convertible preference shares (CCPS) to identified investors on a preferential basis. The allotment was approved by the board of the Sarjapur entity at its meeting held on June 23, 2026, and follows a prior disclosure made by Aster DM Healthcare on February 26, 2026.
The board allotted 12,00,000 fully paid-up Series A CCPS with a face value of Rs 50 each, representing total proceeds of Rs 6 crore to the subsidiary. The board also allotted 34,30,000 partly paid-up Series B CCPS with a face value of Rs 50 each, for which the paid-up amount stands at Rs 5 per share. The allotment was made on terms and conditions previously approved by the shareholders of the Sarjapur entity.
Each Series A CCPS and Series B CCPS carries a conversion ratio under which every preference share will convert into a maximum of up to 5 equity shares of the Sarjapur entity upon conversion. The conversion ratio is applicable as of the allotment date for both series of preference shares.
The Sarjapur entity is pursuing further capital raising and is in the process of finalising additional investors. Further CCPS may be issued to these investors in due course as part of an additional investment round being planned by the subsidiary.
Aster DM Healthcare has stated that its shareholding in the Sarjapur entity will not fall below 75% of the share capital on an as-if converted basis. This commitment holds after the conversion of the allotted Series A CCPS, Series B CCPS, and any additional investment raised by the subsidiary.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.